Accretive associates sbic llc - see footnote investment history in Accretive health inc

Filed on 2010-05-27 by Accretive Investors Sbic Lp SEC CIK 1262312 Form 4

Accession 0001209191-10-030744.txt Sec File: edgar/data/1262312/0001209191-10-030744-index.htm

2010-05-25 Accretive Associates Sbic Llc (CIK 1492319) through See Footnote

Invested in Accretive Health Inc sold 452193 shares at $0 remaining shares owned 0

Series D Convertible Preferred Stock Accretive Health Inc Ah underlying security shares 1772596 underlying security title Common Stock

f2 accretive investors sbic, l.p. directly beneficially owns the reported securities. accretive associates sbic, llc is the general partner of accretive investors sbic, l.p. j. michael cline is the managing member of accretive associates sbic, llc and serves on the board of directors of accretive health, inc. each of accretive investors sbic, l.p. and accretive associates sbic, llc disclaim beneficial ownership of the reported securities except to the extent of any pecuniary interest therein, if any.
f1 each share of series a convertible preferred stock represented herein converted into 1,201.5069 shares of common stock, par value $0.01 per share, of the issuer (the "common stock"), and had no expiration date. each share of series d convertible preferred stock represented herein converted into 3.92 shares of common stock and had no expiration date.


Filed on 2010-05-27 by Accretive Investors Sbic Lp SEC CIK 1262312 Form 4

Accession 0001209191-10-030744.txt Sec File: edgar/data/1262312/0001209191-10-030744-index.htm

2010-05-25 Accretive Associates Sbic Llc (CIK 1492319) through See Footnote

Invested in Accretive Health Inc sold 15927 shares at $0 remaining shares owned 0

Series A Convertible Preferred Stock Accretive Health Inc Ah underlying security shares 19136400 underlying security title Common Stock

f2 accretive investors sbic, l.p. directly beneficially owns the reported securities. accretive associates sbic, llc is the general partner of accretive investors sbic, l.p. j. michael cline is the managing member of accretive associates sbic, llc and serves on the board of directors of accretive health, inc. each of accretive investors sbic, l.p. and accretive associates sbic, llc disclaim beneficial ownership of the reported securities except to the extent of any pecuniary interest therein, if any.
f1 each share of series a convertible preferred stock represented herein converted into 1,201.5069 shares of common stock, par value $0.01 per share, of the issuer (the "common stock"), and had no expiration date. each share of series d convertible preferred stock represented herein converted into 3.92 shares of common stock and had no expiration date.


Filed on 2010-05-27 by Accretive Investors Sbic Lp SEC CIK 1262312 Form 4

Accession 0001209191-10-030744.txt Sec File: edgar/data/1262312/0001209191-10-030744-index.htm

2010-05-25 Accretive Associates Sbic Llc (CIK 1492319) through See Footnote

Invested in Accretive Health Inc bought 603218 shares at $12.00 remaining shares owned 20516866

Common Stock Accretive Health Inc Ah Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f3 reflects shares of common stock received in satisfaction of a liquidation preference required to be made to accretive investors sbic, l.p. in connection with the close of the issuer's initial public offering.
f2 accretive investors sbic, l.p. directly beneficially owns the reported securities. accretive associates sbic, llc is the general partner of accretive investors sbic, l.p. j. michael cline is the managing member of accretive associates sbic, llc and serves on the board of directors of accretive health, inc. each of accretive investors sbic, l.p. and accretive associates sbic, llc disclaim beneficial ownership of the reported securities except to the extent of any pecuniary interest therein, if any.


Filed on 2010-05-27 by Accretive Investors Sbic Lp SEC CIK 1262312 Form 4

Accession 0001209191-10-030744.txt Sec File: edgar/data/1262312/0001209191-10-030744-index.htm

2010-05-25 Accretive Associates Sbic Llc (CIK 1492319) through See Footnote

Invested in Accretive Health Inc sold 129828 shares at $11.28 remaining shares owned 19913648

Common Stock Accretive Health Inc Ah Transaction code: S Open market or private sale of securities

f2 accretive investors sbic, l.p. directly beneficially owns the reported securities. accretive associates sbic, llc is the general partner of accretive investors sbic, l.p. j. michael cline is the managing member of accretive associates sbic, llc and serves on the board of directors of accretive health, inc. each of accretive investors sbic, l.p. and accretive associates sbic, llc disclaim beneficial ownership of the reported securities except to the extent of any pecuniary interest therein, if any.


Filed on 2010-05-27 by Accretive Investors Sbic Lp SEC CIK 1262312 Form 4

Accession 0001209191-10-030744.txt Sec File: edgar/data/1262312/0001209191-10-030744-index.htm

2010-05-25 Accretive Associates Sbic Llc (CIK 1492319) through See Footnote

Invested in Accretive Health Inc sold 865520 shares at $11.28 remaining shares owned 20043476

Common Stock Accretive Health Inc Ah Transaction code: S Open market or private sale of securities

f2 accretive investors sbic, l.p. directly beneficially owns the reported securities. accretive associates sbic, llc is the general partner of accretive investors sbic, l.p. j. michael cline is the managing member of accretive associates sbic, llc and serves on the board of directors of accretive health, inc. each of accretive investors sbic, l.p. and accretive associates sbic, llc disclaim beneficial ownership of the reported securities except to the extent of any pecuniary interest therein, if any.


Filed on 2010-05-27 by Accretive Investors Sbic Lp SEC CIK 1262312 Form 4

Accession 0001209191-10-030744.txt Sec File: edgar/data/1262312/0001209191-10-030744-index.htm

2010-05-25 Accretive Associates Sbic Llc (CIK 1492319) through See Footnote

Invested in Accretive Health Inc bought 20908996 shares remaining shares owned 20908996

Common Stock Accretive Health Inc Ah Transaction code: C Conversion of derivative security (usually options)

f1 each share of series a convertible preferred stock represented herein converted into 1,201.5069 shares of common stock, par value $0.01 per share, of the issuer (the "common stock"), and had no expiration date. each share of series d convertible preferred stock represented herein converted into 3.92 shares of common stock and had no expiration date.
f2 accretive investors sbic, l.p. directly beneficially owns the reported securities. accretive associates sbic, llc is the general partner of accretive investors sbic, l.p. j. michael cline is the managing member of accretive associates sbic, llc and serves on the board of directors of accretive health, inc. each of accretive investors sbic, l.p. and accretive associates sbic, llc disclaim beneficial ownership of the reported securities except to the extent of any pecuniary interest therein, if any.